Table of Contents
FLINT, Mich. — Diplomat Pharmacy and CSI Specialty Group, a globally recognized specialty pharmacy consulting firm, have launched a program for hospitals and health systems interested in starting or expanding their own specialty pharmacy services to benefit from Diplomat’s limited-distribution drug portfolio and expertise treating rare, chronic, and complex diseases.
CSI, a partner of leading national healthcare solutions organization and Intermountain Healthcare company Intalere, offers specialty pharmacy solutions to help health systems improve patient care and optimize access to specialty medications.
Robyn Peters, executive vice president of sales and payer strategies at Diplomat, said the program is designed to address barriers to effective care and increase coordination across the healthcare team.
“We are proud to partner with CSI to provide access to a suite of cost-effective specialty pharmacy services for their hospital members,” Peters said. “Diplomat’s supportive care model offers a unique solution for oncology care management, access to limited-distribution drugs and 340B contract-pharmacy support.”
CSI president and chief executive officer Suzette DiMascio commented, “This partnership has the power to enhance patient care by combining our consultative solutions for health systems with Diplomat’s extensive specialty pharmacy capabilities. Together, we’re optimizing specialty pharmacy services for patients by offering tailored solutions that will deliver lasting financial, operational, and clinical performance excellence.”
The company also has been selected by Hospitality Rx as the exclusive provider of specialty pharmacy and infusion services for its UNITE HERE HEALTH (UHH) plan members.
Robyn Peters
UHH is a multiemployer union plan that provides health benefits to approximately 250,000 members across the nation. Pharmacy benefit management services for most UHH markets are provided by UHH subsidiary Hospitality Rx.
“Diplomat is proud to have earned the trust of Hospitality Rx and UHH,” said Peters. “This partnership means more patients — especially those dealing with complex and chronic conditions — will have access to highly skilled teams who truly understand their needs.”
As part of the agreement, Diplomat will provide services including specialty product fulfillment, reimbursement support, clinical assistance and adherence programs, and data reporting and analytics.
“We believe our success — and the health of our plan members — depends on innovation and strong partnerships,” said Matthew Walker, chief executive officer of UHH. “We partnered with Diplomat to enhance our ability to deliver high-quality care at a great value for our participants.”
